{
  "url": "https://struct.news/briefs/anteris-has-lemaitre-in-four-seats",
  "title": "Anteris Has LeMaitre in Four Seats",
  "summary": "Anteris’s filings place LeMaitre on both sides of its product flow, while Medtronic is investor, partner and competitor.",
  "published_at": "2026-08-31T23:47:28.403126+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "Anteris Technologies Global Corp.",
    "ticker": "AVR",
    "cik": null,
    "sector": "Healthcare",
    "industry": null
  },
  "source_filing": null,
  "comparison_filing": null,
  "reported_figures": [
    {
      "group": "Anteris’s disclosed ties to LeMaitre and Medtronic",
      "label": "LMAT",
      "value": "LMAT",
      "display": "LMAT",
      "unit": "ticker",
      "period": null,
      "detail": null,
      "source": {
        "kind": "jodie_evidence",
        "label": "Named in SEC filings",
        "as_of": "2026-08-31"
      }
    },
    {
      "group": "Anteris’s disclosed ties to LeMaitre and Medtronic",
      "label": "LMAT",
      "value": "LMAT",
      "display": "LMAT",
      "unit": "ticker",
      "period": null,
      "detail": null,
      "source": {
        "kind": "jodie_evidence",
        "label": "Named in SEC filings",
        "as_of": "2026-08-31"
      }
    },
    {
      "group": "Anteris’s disclosed ties to LeMaitre and Medtronic",
      "label": "LMAT",
      "value": "LMAT",
      "display": "LMAT",
      "unit": "ticker",
      "period": null,
      "detail": null,
      "source": {
        "kind": "jodie_evidence",
        "label": "Named in SEC filings",
        "as_of": "2026-08-31"
      }
    },
    {
      "group": "Anteris’s disclosed ties to LeMaitre and Medtronic",
      "label": "LMAT",
      "value": "LMAT",
      "display": "LMAT",
      "unit": "ticker",
      "period": null,
      "detail": null,
      "source": {
        "kind": "jodie_evidence",
        "label": "Named in SEC filings",
        "as_of": "2026-08-31"
      }
    },
    {
      "group": "Anteris’s disclosed ties to LeMaitre and Medtronic",
      "label": "MDT",
      "value": "MDT",
      "display": "MDT",
      "unit": "ticker",
      "period": null,
      "detail": null,
      "source": {
        "kind": "jodie_evidence",
        "label": "Named in SEC filings",
        "as_of": "2026-08-31"
      }
    },
    {
      "group": "Anteris’s disclosed ties to LeMaitre and Medtronic",
      "label": "MDT",
      "value": "MDT",
      "display": "MDT",
      "unit": "ticker",
      "period": null,
      "detail": null,
      "source": {
        "kind": "jodie_evidence",
        "label": "Named in SEC filings",
        "as_of": "2026-08-31"
      }
    },
    {
      "group": "Anteris’s disclosed ties to LeMaitre and Medtronic",
      "label": "LMAT",
      "value": "LMAT",
      "display": "LMAT",
      "unit": "ticker",
      "period": null,
      "detail": null,
      "source": {
        "kind": "jodie_evidence",
        "label": "Named in SEC filings",
        "as_of": "2026-08-31"
      }
    },
    {
      "group": "Anteris’s disclosed ties to LeMaitre and Medtronic",
      "label": "MDT",
      "value": "MDT",
      "display": "MDT",
      "unit": "ticker",
      "period": null,
      "detail": null,
      "source": {
        "kind": "jodie_evidence",
        "label": "Named in SEC filings",
        "as_of": "2026-08-31"
      }
    }
  ],
  "watch_next": [
    {
      "type": "pricing",
      "statement": "LeMaitre attributed higher gross margin to price increases, favorable mix, lower-margin patch sales, and lower shipping costs.",
      "importance": "medium",
      "evidence": "The increase in gross margin was driven primarily by sales price increases, favorable product mix, including decreased sales of comparatively lower margin porcine patches due to the decision to end our distribution agreement with 22 Elutia, and lower shipping costs.",
      "source_date": "2026-08-05"
    },
    {
      "type": "pricing",
      "statement": "The filing attributes the recent gross margin increase primarily to sales price increases, manufacturing efficiencies, and favorable product mix, including reduced lower-margin porcine patch sales after ending Elutia dis",
      "importance": "medium",
      "evidence": "The increase in gross margin was driven primarily by sales price increases, greater manufacturing efficiencies, and favorable product mix, including decreased sales of comparatively lower margin porcine patches due to the decision to end our distribution agreement with Elutia.",
      "source_date": "2026-05-06"
    }
  ],
  "related_tickers": [
    "AORT",
    "AVR",
    "LMAT",
    "MDT"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}